Citations

Showing 10 of 108094 citations.

P3.02: Assessment of Chimerism Testing by Next Generation Sequencing
Brow, Darren, Pettersson, Linnéa, Elrefaei, Mohamed

Mayo Clinic

Transplantation | September 19, 2022 | Volume: 106 | Issue: 9S | Pages: S518-S518

10.1097/01.tp.0000888240.12812.54 Get It

What Is the Role of 2-Pore Domain Potassium Channels (K2P) in Pain?
Benarroch, Eduardo E.

Mayo Clinic

Neurology | September 19, 2022 | Volume: 99 | Issue: 12 | Pages: 516-521

10.1212/wnl.0000000000201197 | PMID 36123135 Get It

413.1: The Impact of UNOS Acuity Circles-Based Organ Allocation on DCD Liver Transplant Rates and Waitlist Mortality in the United States
Wallace, David , Burdine, Lyle , Patel, Raj , Rude, Mary K., Balong, Julius, Wells, Allison Childs, Krinock, Derek , Singer, Andrew L., Mathur, Amit K. , Giorgakis, Emmanouil , Ivanics, Tommy , Wells, Allison, Hardgrave, Hailey

Mayo Clinic

Transplantation | September 19, 2022 | Volume: 106 | Issue: 9S | Pages: S409-S409

10.1097/01.tp.0000887652.80903.2e Get It

White Blood Cells and Chronic Rhinosinusitis: A Mendelian Randomization Study
Pongdee, Thanai , Decker, Paul A. , Kita, Hirohito , Larson, Nicholas B. , Kita, H , Larson, Nicholas B , Bielinski, Suzette J. , Decker, Paul A.

Mayo Clinic

No container title available | September 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2066263/v1 Get It

Abstract Background Risk factors for the pathogenesis of chronic rhinosinusitis (CRS) remain largely undetermined, which is likely due to the heterogeneity of the disease. White blood cell counts have been largely unexplored as a risk factor for CRS even though different types of white blood cells are involved in the inflammatory process of CRS. Objective To investigate causal associations between different types of white blood cells on risk of CRS utilizing a Mendelian randomization (MR) analysis. Methods A two-sample MR analysis was performed using respective GWAS summary statistics for the exposure traits (neutrophil count, eosinophil count, basophil count, lymphocyte count, and monocyte count) and outcome trait (CRS). For the exposure traits, the European Bioinformatics Institute database of complete GWAS summary data was used. For the outcome trait, summary statistics for CRS GWAS were obtained from FinnGen. Primary analysis for MR was performed using inverse-variance weighted two-sample MR. Sensitivity analyses included weighted median, MR-Egger, and MR-PRESSO (raw and outlier-corrected). Results Eosinophils were associated with CRS (OR = 1.55 [95%CI 1.38,1.73]; p = 4.3E-14). Eosinophil results were similar across additional MR methods. MR results did not demonstrate significant causal relationships between neutrophils, lymphocytes, monocytes, or basophils with CRS. No significant pleiotropic bias was observed. Conclusions In a two-sample MR analysis, a potential causal link between blood eosinophil counts and CRS has been demonstrated. In addition, causal relationships between blood counts among other white blood cell types and CRS were not found. Further studies involving genetic variation in CRS are needed to corroborate genetic causal effects for CRS.
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Mao, Jun J. , Ismaila, Nofisat , Bao, Ting , Barton, Debra L. , Ben‐Arye, Eran , Garland, Eric L. , Greenlee, Heather , LeBlanc, Thomas W. , Lee, Richard T. , López, Ana María , Loprinzi, Charles L. , MacLeod, Jodi , Master, Viraj A. , Ramchandran, Kavitha , Walker, Eleanor , Witt, Claudia M. , Barton, Debra , Leblanc, Thomas , Loprinzi, Charles , Lyman, Gary H , MacLeod, Jodi , Wagner, Lynne , Bruner, Deborah , Witt, Claudia M , Bruera, Eduardo , Mao, Jun J , Ramchandran, Kavitha J , Wagner, Lynne I. , Bruner, Deborah Watkins

Mayo Clinic

Journal of Clinical Oncology | September 19, 2022 | Volume: 40 | Issue: 34 | Pages: 3998-4024

10.1200/jco.22.01357 | PMID 36122322 Get It

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS The literature search identified 227 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS Among adult patients, acupuncture should be recommended for aromatase inhibitor–related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer. Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines .
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Ghusn, Wissam , Rosa, Alan De la , Sacoto, Daniel , Cifuentes, Lizeth , Campos, Alejandro , Feris, Fauzi , De la Rosa, Alan, Hurtado, Maria Daniela , Ghusn, Wissam , Campos, Alejandro , Hurtado, Maria D. , Acosta, Andrés

Mayo Clinic

JAMA Network Open | September 19, 2022 | Volume: 5 | Issue: 9 | Pages: e2231982

10.1001/jamanetworkopen.2022.31982 | PMID 36121652 Get It

ImportanceNo retrospective cohort study has assessed the effectiveness of semaglutide at doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg).ObjectiveTo study weight loss outcomes associated with semaglutide treatment at doses used in randomized clinical trials for patients with overweight or obesity.Design, Setting, and ParticipantsThis cohort study, conducted at a referral center for weight management, retrospectively collected data on the use of semaglutide for adults with overweight or obesity between January 1, 2021, and March 15, 2022, with a follow-up of up to 6 months. A total of 408 patients with a body mass index (BMI) of 27 or more were prescribed weekly semaglutide subcutaneous injections for 3 months or more. Patients with a history of bariatric procedures, taking other antiobesity medications, and with an active malignant neoplasm were excluded.ExposuresWeekly 1.7-mg or 2.4-mg semaglutide subcutaneous injections for 3 to 6 months.Main Outcomes and MeasuresThe primary end point was the percentage of weight loss. Secondary end points were the proportion of patients achieving weight loss of 5% or more, 10% or more, 15% or more, and 20% or more after 3 and 6 months and the percentage of weight loss for patients with or without type 2 diabetes after 3 and 6 months.ResultsThe study included 175 patients (132 women [75.4%]; mean [SD] age, 49.3 [12.5] years; mean [SD] BMI, 41.3 [9.1]) in the analysis at 3 months and 102 patients at 6 months. The mean (SD) weight loss after 3 months was 6.7 (4.4) kg, equivalent to a mean (SD) weight loss of 5.9% (3.7%) (P < .001), and the mean (SD) weight loss after 6 months was 12.3 (6.6) kg, equivalent to a mean (SD) weight loss of 10.9% (5.8%) (P < .001 from baseline). Of the 102 patients who were followed up at 6 months, 89 (87.3%) achieved weight loss of 5% or more, 56 (54.9%) achieved weight loss of 10% or more, 24 (23.5%) achieved weight loss of 15% or more, and 8 (7.8%) achieved weight loss of 20% or more. Patients with type 2 diabetes had a lower mean (SD) percentage weight loss at 3 and 6 months compared with those without type 2 diabetes: 3.9% (3.1%) vs 6.3% (3.7%) at 3 months (P = .001) and 7.2% (6.3%) vs 11.8% (5.3%) at 6 months (P = .005).Conclusions and RelevanceThe results of this cohort study suggest that weekly 1.7-mg and 2.4-mg doses of semaglutide were associated with weight loss similar to that seen in randomized clinical trials. Studies with longer periods of follow-up are needed to evaluate prolonged weight loss outcomes.
Clinical Laboratory Utility of a Humanized Antibody in Commercially Available Enzyme Immunoassays for Coccidioidomycosis
Grill, Francisca J. , Jugler, Collin , Kaleta, Erin, Chen, Qiang , Magee, D. Mitchell, Grys, Thomas E. , Lake, Douglas F. , Grys, Thomas E , Lake, Douglas F

Mayo Clinic

Microbiology Spectrum | September 19, 2022 | Volume: 10 | Issue: 5 | Pages: No page available

10.1128/spectrum.02573-22 | PMID 36121238 Get It

In southwestern and western regions of the United States, at least half a million diagnostic tests for coccidioidomycosis (valley fever) are run annually. Enzyme immunoassays (EIAs) are blood tests which require precise dilution of patient serum prior to testing.
Hepatology highlights
Povero, Davide , Parthasarathy, Gopanandan , Idalsoaga, Francisco , Ilyas, Sumera I. , Ilyas, Sumera Irie , Wu, Tiffany , Arab, Juan Pablo

Mayo Clinic

Hepatology | September 19, 2022 | Volume: 76 | Issue: 4 | Pages: 901-902

10.1002/hep.32683 Get It

The ‘perfect’ lens: Perfectionism and early adolescents' math self‐efficacy development
Ford, Calah J. , Usher, Ellen L. , Scott, Veronica L., Chen, Xiao‐Yin , Usher, Ellen L , Scott, Veronica L.

Mayo Clinic

British Journal of Educational Psychology | September 19, 2022 | Volume: 93 | Issue: 1 | Pages: 211-228

10.1111/bjep.12550 | PMID 36121038 Get It

Abstract Background Self‐efficacy, or the beliefs learners hold about what they can do, develops largely from how learners perceive and interpret four main sources of information: mastery experiences, vicarious experiences, social persuasions and physiological and affective states. Although the relationship between these sources and self‐efficacy is well‐established, less is known about the factors that may influence how early adolescent learners perceive and interpret information from these sources. Aims The purpose of this study was to investigate how the predisposition of perfectionism might predict how learners perceive efficacy‐relevant information in the domain of math. Methods Using a correlational design, this study considered whether perfectionism was associated with how middle school students ( N = 1683) perceive information from the four hypothesized sources of self‐efficacy. Participants completed a paper‐based survey at two time points. Perfectionism was measured at Time 1. Self‐efficacy and its sources were measured at Time 2. Structural equation modelling techniques were used to examine the relationship between factors. Results and Conclusions Students who held themselves to high standards (i.e., greater self‐oriented perfectionism) reported higher levels of mastery experiences, vicarious experiences, social messages and self‐efficacy. Conversely, students who felt external pressure to be perfect (i.e., socially prescribed perfectionism) reported lower levels of mastery experiences, vicarious experiences and self‐efficacy, as well as higher levels of negative physiological and affective states. The relationship between perfectionism and self‐efficacy was partially mediated by students' perceptions of mastery. This study extends the current literature on the sources of math self‐efficacy in early adolescence by showing how a predisposition like perfectionism is associated with how adolescent learners perceive and interpret efficacy‐relevant information.
The relationship between muscle sympathetic nerve activity and systemic hemodynamics is altered in women with uterine fibroids
Laughlin-Tommaso, S.K., Limberg, Jacqueline K. , Joyner, Michael J. , Barnes, Jill N. , Harvey, Ronée E , Curry, Timothy B. , Barnes, J N , Joyner, Michael J , Harvey, Ronée E. , Stewart, Elizabeth A.

Mayo Clinic

Physiological Reports | September 19, 2022 | Volume: 10 | Issue: 18 | Pages: No page available

10.14814/phy2.15445 | PMID 36117415 Get It